Methods of treating developmental syndromes with PDE10A inhibitors

Floyd R. Sallee, Erik B. Nelson, Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine ,(2006)

Robert M. Rzasa, Paul E. Harrington, Alexander J. Pickrell, Jennifer R. Allen, Michael J. Frohn, Kristin L. Andrews, Aryl- and heteroaryl- nitrogen-heterocyclic compounds as pde10 inhibitors ,(2011)

A. Nishi, M. Kuroiwa, D. B. Miller, J. P. O'Callaghan, H. S. Bateup, T. Shuto, N. Sotogaku, T. Fukuda, N. Heintz, P. Greengard, G. L. Snyder, Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum The Journal of Neuroscience. ,vol. 28, pp. 10460- 10471 ,(2008) , 10.1523/JNEUROSCI.2518-08.2008

Akina Harada, Kazunori Suzuki, Naomi Kamiguchi, Maki Miyamoto, Kimio Tohyama, Kosuke Nakashima, Takahiko Taniguchi, Haruhide Kimura, Characterization of Binding and Inhibitory Properties of TAK-063, a Novel Phosphodiesterase 10A Inhibitor PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0122197

Kazunori Suzuki, Akina Harada, Eri Shiraishi, Haruhide Kimura, In vivo pharmacological characterization of TAK-063, a potent and selective phosphodiesterase 10A inhibitor with antipsychotic-like activity in rodents. Journal of Pharmacology and Experimental Therapeutics. ,vol. 352, pp. 471- 479 ,(2015) , 10.1124/JPET.114.218552

Jun Kunitomo, Masato Yoshikawa, Makoto Fushimi, Akira Kawada, John F. Quinn, Hideyuki Oki, Hironori Kokubo, Mitsuyo Kondo, Kosuke Nakashima, Naomi Kamiguchi, Kazunori Suzuki, Haruhide Kimura, Takahiko Taniguchi, Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. Journal of Medicinal Chemistry. ,vol. 57, pp. 9627- 9643 ,(2014) , 10.1021/JM5013648

Jun Kunitomo, Takahiko Taniguchi, 1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound ,(2010)

Pascal Danglas, Michael Reidy, Paul Korner, Sudarkodi Alagarsamy, Method of treating prader-willi syndrome ,(2015)

Matthew During, Methods of treating Prader-Willi syndrome ,(2016)

María del Mar Cuadrado Tejedor, Maria Obdulia Rabal Gracia, Julen Oyarzabal Santamarina, Ana María García Osta, Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases ,(2015)